Chickenpox Exposure in Pregnancy: Risks, Management & Prevention

Varicella-zoster virus (VZV) exposure during pregnancy requires urgent evaluation. While 90%+ of adults are immune, susceptible pregnant women face significant maternal and fetal risks.

Immediate Steps

  1. Confirm immune status: Check vaccination history (2-dose varicella vaccine) or prior chickenpox/shingles. If uncertain → stat VZV IgG antibody test.
  2. If immune (IgG+): Reassure; no further action needed.
  3. If non-immune (IgG-): Proceed below.

Post-Exposure Prophylaxis (PEP)

  • Varicella-Zoster Immune Globulin (VariZIG®): 125 units/10kg IM (max 625 units) within 10 days of exposure (ideally ≤96h). Reduces severity/incidence. Indicated for: pregnant, immunocompromised, neonates.
  • Alternative: IVIG (400 mg/kg) if VariZIG unavailable.
  • Vaccine (live attenuated) CONTRAINDICATED in pregnancy. Give postpartum if still susceptible.

If Chickenpox Develops

  • Antiviral Therapy: Oral Acyclovir 800mg 5x/day ×7 days (Valacyclovir 1g TID, Famciclovir 500mg TID alternatives). Start within 24h of rash onset. Reduces maternal complications (pneumonitis 10-20% risk in pregnancy).
  • IV Acyclovir for severe disease (pneumonitis, encephalitis, disseminated). Hospitalize.
  • Supportive: Hydration, antipyretics (acetaminophen; avoid NSAIDs), antihistamines for pruritus.

Fetal Risks by Gestational Age

TimingRisk
≤20 weeksCongenital Varicella Syndrome (CVS): ~1-2% risk. Microcephaly, limb hypoplasia, cataracts, chorioretinitis, skin scarring, neurodevelopmental delay.
20-28 weeksCVS rare; fetal infection possible → asymptomatic or herpes zoster in infancy/childhood.
Peripartum (5 days before - 2 days after delivery)Neonatal Varicella: 20-30% severe/disseminated; high mortality without treatment. Mother lacks time to transfer IgG. Give neonate VariZIG + acyclovir.

Monitoring & Delivery

  • Serial Ultrasounds: q4-6 weeks from 16-20w to detect CVS features (limb reduction, echogenic foci, IUGR, hydrops).
  • Amniocentesis (PCR for VZV DNA): After 16w, ≥4 weeks post-infection. Positive = fetal infection; not predictive of severity.
  • Delivery Timing: Delay ≥5-7 days after maternal rash onset if possible (allows IgG transfer). C-section not routinely indicated for maternal varicella alone.

Breastfeeding

Safe if mother has active lesions not on breast. Cover lesions; hand hygiene. If lesions on areola → express/discard milk from that side until crusted. Antivirals compatible.

Prevention

  • Screen for VZV immunity preconception/early prenatal.
  • Vaccinate susceptible non-pregnant women (2 doses, 4-8 weeks apart). Avoid pregnancy 1 month post-vaccine.
  • Household contacts of pregnant women should be immune/vaccinated.

VZV in pregnancy is manageable with prompt action. The keys: know immune status, give VariZIG rapidly if susceptible, start antivirals early if disease develops, monitor fetus, time delivery for antibody transfer.

Pregnancy & Health - Related Articles